· 📍 New Orleans, USA · India
After the American College of Cardiology (ACC) 2026 conference in New Orleans, a pan-India expert meeting reviewed updated hypertension guidelines. Despite strong support from the ACC/AHA, ESC, and ESH for early single-pill combination therapy, only about 13.8% of Indian patients receive it. The new emphasis is on starting combination therapy sooner to better protect the heart, kidneys, and brain.
What is a single-pill combination?
A single tablet that combines two (or three) BP-lowering medicines at fixed low doses — typically an ACE inhibitor or ARB with a calcium-channel blocker and/or a thiazide-like diuretic. Combining mechanisms gets BP to target faster, with fewer side effects than maximising a single drug.
Why it matters for you
Ask your cardiologist whether a single-pill combination is right for you. Fewer tablets often mean better long-term adherence — and better BP control means lower lifetime risk of heart attack, stroke, and kidney disease.